@article{67a6241b6aec457c845e9e9ab3971365,
title = "P548 Ustekinumab shows favourable safety profile and drug persistence rates in patients with Crohns Disease results from a tertiary IBD centre",
keywords = "Ustekinumab, Crohn's disease, Medicine, Persistence (discontinuity), Drug, Disease, Internal medicine, Dermatology, Pharmacology, Adalimumab, Geotechnical engineering, Engineering",
author = "Subrata Ghosh",
year = "2024",
doi = "10.1093/ecco-jcc/jjad212.0678",
language = "English",
journal = "Journal of Crohn's and Colitis",
issn = "1873-9946",
publisher = "Oxford University Press",
}